company background image
GXH

Green Cross HealthNZSE:GXH Stock Report

Market Cap

NZ$183.2m

7D

4.1%

1Y

24.3%

Updated

17 Oct, 2021

Data

Company Financials
GXH fundamental analysis
Snowflake Score
Valuation5/6
Future Growth0/6
Past Performance4/6
Financial Health5/6
Dividends0/6

GXH Overview

Green Cross Health Limited provides health support, care, and advice services to communities in New Zealand.

Price History & Performance

Summary of all time highs, changes and price drops for Green Cross Health
Historical stock prices
Current Share PriceNZ$1.28
52 Week HighNZ$1.02
52 Week LowNZ$1.28
Beta0.28
1 Month Change10.35%
3 Month Change8.48%
1 Year Change24.27%
3 Year Change-4.48%
5 Year Change-52.59%
Change since IPO166.67%

Recent News & Updates

May 04
Capital Allocation Trends At Green Cross Health (NZSE:GXH) Aren't Ideal

Capital Allocation Trends At Green Cross Health (NZSE:GXH) Aren't Ideal

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Mar 14
Green Cross Health (NZSE:GXH) Share Prices Have Dropped 58% In The Last Five Years

Green Cross Health (NZSE:GXH) Share Prices Have Dropped 58% In The Last Five Years

The main aim of stock picking is to find the market-beating stocks. But even the best stock picker will only win with...

Feb 12
Is Green Cross Health Limited (NZSE:GXH) Popular Amongst Insiders?

Is Green Cross Health Limited (NZSE:GXH) Popular Amongst Insiders?

The big shareholder groups in Green Cross Health Limited ( NZSE:GXH ) have power over the company. Large companies...

Jan 28
Has Green Cross Health (NZSE:GXH) Got What It Takes To Become A Multi-Bagger?

Has Green Cross Health (NZSE:GXH) Got What It Takes To Become A Multi-Bagger?

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...

Shareholder Returns

GXHNZ Consumer RetailingNZ Market
7D4.1%1.2%-0.5%
1Y24.3%3.5%2.2%

Return vs Industry: GXH exceeded the NZ Consumer Retailing industry which returned 3.5% over the past year.

Return vs Market: GXH exceeded the NZ Market which returned 2.2% over the past year.

Price Volatility

Is GXH's price volatile compared to industry and market?
GXH volatility
GXH Beta0.28
Industry Beta0.57
Market Beta1

Stable Share Price: GXH is not significantly more volatile than the rest of NZ stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: GXH's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19995,700Rachael Newfieldhttps://www.greencrosshealth.co.nz

Green Cross Health Limited provides health support, care, and advice services to communities in New Zealand. It operates in three segments: Pharmacy Services, Medical Services, and Community Health. The Pharmacy Services segment offers pharmacy services through stores, equity accounted investments, and franchise stores.

Green Cross Health Fundamentals Summary

How do Green Cross Health's earnings and revenue compare to its market cap?
GXH fundamental statistics
Market CapNZ$183.24m
Earnings (TTM)NZ$16.75m
Revenue (TTM)NZ$570.40m

10.9x

P/E Ratio

0.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
GXH income statement (TTM)
RevenueNZ$570.40m
Cost of RevenueNZ$510.86m
Gross ProfitNZ$59.54m
ExpensesNZ$42.79m
EarningsNZ$16.75m

Last Reported Earnings

Mar 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.12
Gross Margin10.44%
Net Profit Margin2.94%
Debt/Equity Ratio16.3%

How did GXH perform over the long term?

See historical performance and comparison

Valuation

Is Green Cross Health undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: GXH (NZ$1.28) is trading below our estimate of fair value (NZ$20.09)

Significantly Below Fair Value: GXH is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: GXH is good value based on its PE Ratio (10.9x) compared to the Oceanic Consumer Retailing industry average (25.7x).

PE vs Market: GXH is good value based on its PE Ratio (10.9x) compared to the NZ market (22.5x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate GXH's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: GXH is good value based on its PB Ratio (1.3x) compared to the XO Consumer Retailing industry average (3.7x).


Future Growth

How is Green Cross Health forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

3.9%

Forecasted Consumer Retailing industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Green Cross Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Green Cross Health performed over the past 5 years?

-5.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: GXH has high quality earnings.

Growing Profit Margin: GXH's current net profit margins (2.9%) are higher than last year (2.4%).


Past Earnings Growth Analysis

Earnings Trend: GXH's earnings have declined by 5.1% per year over the past 5 years.

Accelerating Growth: GXH's earnings growth over the past year (24.2%) exceeds its 5-year average (-5.1% per year).

Earnings vs Industry: GXH earnings growth over the past year (24.2%) exceeded the Consumer Retailing industry 13.2%.


Return on Equity

High ROE: GXH's Return on Equity (14.1%) is considered low.


Financial Health

How is Green Cross Health's financial position?


Financial Position Analysis

Short Term Liabilities: GXH's short term assets (NZ$108.5M) do not cover its short term liabilities (NZ$121.8M).

Long Term Liabilities: GXH's short term assets (NZ$108.5M) exceed its long term liabilities (NZ$93.5M).


Debt to Equity History and Analysis

Debt Level: GXH's debt to equity ratio (16.3%) is considered satisfactory.

Reducing Debt: GXH's debt to equity ratio has reduced from 76.8% to 16.3% over the past 5 years.

Debt Coverage: GXH's debt is well covered by operating cash flow (291%).

Interest Coverage: GXH's interest payments on its debt are well covered by EBIT (5.5x coverage).


Balance Sheet


Dividend

What is Green Cross Health current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate GXH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate GXH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if GXH's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if GXH's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: GXH is not paying a notable dividend for the NZ market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of GXH's dividend in 3 years as they are not forecast to pay a notable one for the NZ market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.2yrs

Average management tenure


CEO

Rachael Newfield

2.75yrs

Tenure

Ms. Rachael Newfield has been the Group Chief Executive Officer of Green Cross Health Limited since January 2019.


Leadership Team

Experienced Management: GXH's management team is considered experienced (3.2 years average tenure).


Board Members

Experienced Board: GXH's board of directors are considered experienced (9.6 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Green Cross Health Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Green Cross Health Limited
  • Ticker: GXH
  • Exchange: NZSE
  • Founded: 1999
  • Industry: Drug Retail
  • Sector: Consumer Retailing
  • Market Cap: NZ$183.236m
  • Shares outstanding: 143.15m
  • Website: https://www.greencrosshealth.co.nz

Number of Employees


Location

  • Green Cross Health Limited
  • Building B
  • Ground Floor
  • Auckland
  • 1051
  • New Zealand

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/17 06:02
End of Day Share Price2021/10/15 00:00
Earnings2021/03/31
Annual Earnings2021/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.